ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04380	Osteoclast differentiation	44/407	134/7206	6.30422609795e-23
ko04060	Cytokine-cytokine receptor interaction	46/407	191/7206	8.12117194351e-18
ko04064	NF-kappa B signaling pathway	31/407	96/7206	3.29883153381e-16
ko04621	NOD-like receptor signaling pathway	39/407	157/7206	9.8454749588e-16
ko05164	Influenza A	39/407	167/7206	9.1161551687e-15
ko05162	Measles	31/407	120/7206	3.16052719557e-13
ko05140	Leishmaniasis	24/407	75/7206	1.01856067316e-12
ko05168	Herpes simplex infection	37/407	182/7206	4.31045919929e-12
ko04620	Toll-like receptor signaling pathway	26/407	100/7206	2.34759490481e-11
ko05152	Tuberculosis	36/407	187/7206	4.49386902881e-11
ko04217	Necroptosis	35/407	178/7206	4.5586391663e-11
ko04668	TNF signaling pathway	28/407	120/7206	6.50112760669e-11
ko05161	Hepatitis B	34/407	173/7206	8.88075574461e-11
ko05145	Toxoplasmosis	28/407	126/7206	2.21835283504e-10
ko04659	Th17 cell differentiation	25/407	106/7206	5.54545861206e-10
ko05321	Inflammatory bowel disease (IBD)	18/407	56/7206	6.86571570379e-10
ko04610	Complement and coagulation cascades	21/407	79/7206	1.31929745831e-09
ko04650	Natural killer cell mediated cytotoxicity	23/407	97/7206	2.47187620763e-09
ko05150	Staphylococcus aureus infection	14/407	36/7206	3.26401756914e-09
ko04660	T cell receptor signaling pathway	26/407	124/7206	3.75657144674e-09
ko04630	Jak-STAT signaling pathway	26/407	132/7206	1.5049054159e-08
ko05167	Kaposi's sarcoma-associated herpesvirus infection	32/407	191/7206	2.04420650226e-08
ko05340	Primary immunodeficiency	12/407	30/7206	3.06747494813e-08
ko05133	Pertussis	20/407	87/7206	4.86807241104e-08
ko04672	Intestinal immune network for IgA production	13/407	37/7206	5.05803082527e-08
ko04658	Th1 and Th2 cell differentiation	21/407	96/7206	5.66183104919e-08
ko05323	Rheumatoid arthritis	20/407	89/7206	7.31447400228e-08
ko05144	Malaria	14/407	45/7206	8.9718258779e-08
ko04622	RIG-I-like receptor signaling pathway	16/407	62/7206	1.98082551765e-07
ko05142	Chagas disease (American trypanosomiasis)	23/407	130/7206	7.88079893267e-07
ko05160	Hepatitis C	25/407	153/7206	1.2264828307e-06
ko04662	B cell receptor signaling pathway	18/407	88/7206	1.4573080921e-06
ko04623	Cytosolic DNA-sensing pathway	12/407	41/7206	1.58541831843e-06
ko05320	Autoimmune thyroid disease	9/407	29/7206	1.94836147503e-05
ko04657	IL-17 signaling pathway	16/407	87/7206	2.32503213437e-05
ko05330	Allograft rejection	8/407	24/7206	3.18987691772e-05
ko04640	Hematopoietic cell lineage	13/407	64/7206	4.60149135532e-05
ko04933	AGE-RAGE signaling pathway in diabetic complications	20/407	135/7206	6.22545655947e-05
ko04062	Chemokine signaling pathway	26/407	201/7206	6.44324148339e-05
ko04612	Antigen processing and presentation	14/407	77/7206	8.56158780843e-05
ko04210	Apoptosis	24/407	180/7206	9.28045602313e-05
ko04145	Phagosome	22/407	162/7206	0.000103392025446
ko05132	Salmonella infection	16/407	98/7206	0.000104886956794
ko05134	Legionellosis	13/407	74/7206	0.000218832494805
ko05310	Asthma	6/407	17/7206	0.000227128208619
ko00120	Primary bile acid biosynthesis	6/407	20/7206	0.000615337652343
ko05131	Shigellosis	13/407	82/7206	0.00061804566335
ko05034	Alcoholism	3/407	238/7206	0.000882638148336
ko04670	Leukocyte transendothelial migration	19/407	151/7206	0.00094110995497
ko04664	Fc epsilon RI signaling pathway	12/407	77/7206	0.0011599053634
ko05166	HTLV-I infection	30/407	292/7206	0.00162416971543
ko05418	Fluid shear stress and atherosclerosis	20/407	173/7206	0.00214587260089
ko04724	Glutamatergic synapse	1/407	152/7206	0.00222798213384
ko05012	Parkinson's disease	1/407	155/7206	0.00226097645872
ko05332	Graft-versus-host disease	5/407	18/7206	0.00260323073962
ko04611	Platelet activation	19/407	163/7206	0.00276029135618
ko05169	Epstein-Barr virus infection	22/407	206/7206	0.00333001218612
ko05146	Amoebiasis	13/407	99/7206	0.00358707632571
ko04666	Fc gamma R-mediated phagocytosis	15/407	122/7206	0.00425936942588
ko00140	Steroid hormone biosynthesis	7/407	41/7206	0.00737212328083
ko04940	Type I diabetes mellitus	6/407	32/7206	0.00809579144417
ko05143	African trypanosomiasis	6/407	32/7206	0.00809579144417
ko05016	Huntington's disease	4/407	215/7206	0.0100755327157
ko01200	Carbon metabolism	1/407	128/7206	0.010307591159
ko04931	Insulin resistance	15/407	137/7206	0.0131631166226
ko04310	Wnt signaling pathway	3/407	181/7206	0.0134291703469
ko04360	Axon guidance	5/407	233/7206	0.0136581089904
ko04728	Dopaminergic synapse	3/407	185/7206	0.0139593507133
ko04151	PI3K-Akt signaling pathway	33/407	390/7206	0.0175060366875
ko04514	Cell adhesion molecules (CAMs)	14/407	130/7206	0.018976315203
ko04727	GABAergic synapse	1/407	110/7206	0.0209892299575
ko05032	Morphine addiction	1/407	110/7206	0.0209892299575
ko04972	Pancreatic secretion	1/407	111/7206	0.0210530528027
ko05020	Prion diseases	6/407	40/7206	0.0234856255393
ko04916	Melanogenesis	2/407	142/7206	0.0250774842475
ko04550	Signaling pathways regulating pluripotency of stem cells	3/407	165/7206	0.0255821296458
ko04144	Endocytosis	29/407	342/7206	0.0295886014112
ko04920	Adipocytokine signaling pathway	10/407	89/7206	0.0332683530698
ko05215	Prostate cancer	12/407	111/7206	0.0338290175507
ko05416	Viral myocarditis	7/407	55/7206	0.0339527004893
ko04713	Circadian entrainment	2/407	136/7206	0.0357819419375
ko05120	Epithelial cell signaling in Helicobacter pylori infection	10/407	92/7206	0.0385714564898
ko05200	Pathways in cancer	38/407	492/7206	0.0429255170298
ko04512	ECM-receptor interaction	9/407	79/7206	0.0430292512837
ko05010	Alzheimer's disease	5/407	202/7206	0.0440791651478
ko04260	Cardiac muscle contraction	1/407	98/7206	0.0441689308224
ko00190	Oxidative phosphorylation	2/407	127/7206	0.0489500148611